Testing for Mycoplasma genitalium and Using Doxycycline as First-Line Therapy at Initial Presentations for Non-Gonococcal Urethritis (NGU) Correlate With Reductions in Persistent NGU.
Clin Infect Dis
; 76(9): 1674-1677, 2023 05 03.
Article
em En
| MEDLINE
| ID: mdl-36575605
ABSTRACT
We found that the odds of return clinic visits for persistent non-gonococcal urethritis (NGU) were significantly lower (odds ratio .4; 95% confidence interval .3-.6; P < .0001) after implementing (1) testing for Mycoplasma genitalium during initial evaluations for NGU and (2) switching from azithromycin to doxycycline as first-line NGU treatment.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Uretrite
/
Mycoplasma genitalium
/
Infecções por Mycoplasma
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article